Involvement of Metabotropic Glutamate Receptor 5 in Brain Reward Deficits Associated with Cocaine and Nicotine Withdrawal and Somatic Signs of Nicotine Withdrawal
Overview
Affiliations
Rationale: The involvement of metabotropic glutamate 5 (mGlu5) receptors has been suggested in the reinforcing effects of psychostimulants. However, little is known about the role of these receptors in psychostimulant withdrawal.
Objectives: The role of mGlu5 receptors was assessed in the anhedonic and somatic aspects of psychostimulant withdrawal.
Methods: Anhedonia was assessed with the discrete-trial current-intensity intracranial self-stimulation (ICSS) procedure after the termination of cocaine (180 mg kg(-1) day(-1), salt, 3 days, i.p.) or nicotine (40 mg kg(-1) day(-1), base, 28 days, s.c.) administration via osmotic minipumps in mGlu5 receptor knockout (mGluR5(-/-)) and wild-type (mGluR5(+/+)) mice. Somatic signs were assessed during nicotine withdrawal. The effects of the nicotinic acetylcholine receptor antagonist mecamylamine on ICSS thresholds were assessed during chronic nicotine administration.
Results: Nicotine-treated mGluR5(+/+) and mGluR5(-/-) mice demonstrated similar threshold elevations during mecamylamine-precipitated withdrawal compared with their saline-treated counterparts. During spontaneous nicotine and cocaine withdrawal, thresholds in drug-withdrawing mGluR5(+/+), but not mGluR5(-/-), mice were elevated up to 72 h of nicotine/cocaine withdrawal and then returned to baseline, indicating attenuation of withdrawal-induced anhedonia in mGluR5(-/-) mice. Nicotine-withdrawing mGluR5(+/+), but not mGluR5(-/-), mice showed increases in somatic signs compared with saline-treated counterparts.
Conclusions: mGlu5 receptor null mutation attenuates the anhedonic and somatic effects of psychostimulant withdrawal. This attenuated withdrawal in mGluR5(-/-) mice may result from the lack of drug-induced adaptations in mGlu5 receptor function that may occur in mGluR5(+/+) mice with chronic drug administration. Thus, these results suggest the involvement of mGlu5 receptors in psychostimulant dependence and the mediation of the anhedonic and somatic signs of psychostimulant withdrawal.
Alegre-Zurano L, Caceres-Rodriguez A, Berbegal-Saez P, Lassalle O, Manzoni O, Valverde O Sci Rep. 2023; 13(1):18229.
PMID: 37880305 PMC: 10600200. DOI: 10.1038/s41598-023-45476-7.
Carrette L, Kimbrough A, Davoudian P, Kwan A, Collazo A, George O eNeuro. 2023; 10(6).
PMID: 37295945 PMC: 10306126. DOI: 10.1523/ENEURO.0019-23.2023.
Carrette L, Kimbrough A, Davoudian P, Kwan A, Collazo A, George O bioRxiv. 2023; .
PMID: 37034602 PMC: 10081261. DOI: 10.1101/2023.03.29.534836.
Kimbrough A, Kallupi M, Smith L, Simpson S, Collazo A, George O eNeuro. 2021; 8(6).
PMID: 34580158 PMC: 8570684. DOI: 10.1523/ENEURO.0208-19.2021.
Borland J, Kim E, Swanson S, Rothwell P, Mermelstein P, Meisel R Front Behav Neurosci. 2020; 14:583395.
PMID: 33328919 PMC: 7719767. DOI: 10.3389/fnbeh.2020.583395.